{"Title": "Downregulated Wnt/\u03b2-catenin signalling in the Down syndrome hippocampus", "Year": 2019, "Source": "Sci. Rep.", "Volume": "9", "Issue": 1, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 2, "DOI": "10.1038/s41598-019-43820-4", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065697947&origin=inward", "Abstract": "\u00a9 2019, The Author(s).Pathological mechanisms underlying Down syndrome (DS)/Trisomy 21, including dysregulation of essential signalling processes remain poorly understood. Combining bioinformatics with RNA and protein analysis, we identified downregulation of the Wnt/\u03b2-catenin pathway in the hippocampus of adult DS individuals with Alzheimer\u2019s disease and the \u2018Tc1\u2019 DS mouse model. Providing a potential underlying molecular pathway, we demonstrate that the chromosome 21 kinase DYRK1A regulates Wnt signalling via a novel bimodal mechanism. Under basal conditions, DYRK1A is a negative regulator of Wnt/\u03b2-catenin. Following pathway activation, however, DYRK1A exerts the opposite effect, increasing signalling activity. In summary, we identified downregulation of hippocampal Wnt/\u03b2-catenin signalling in DS, possibly mediated by a dose dependent effect of the chromosome 21-encoded kinase DYRK1A. Overall, we propose that dosage imbalance of the Hsa21 gene DYRK1A affects downstream Wnt target genes. Therefore, modulation of Wnt signalling may open unexplored avenues for DS and Alzheimer\u2019s disease treatment.", "AuthorKeywords": null, "IndexKeywords": ["Adaptor Proteins, Signal Transducing", "Aged", "Alzheimer Disease", "Animals", "Axin Protein", "Catechin", "Chromosomes, Human, Pair 21", "Disease Models, Animal", "Down Syndrome", "Down-Regulation", "Female", "HEK293 Cells", "HeLa Cells", "Hippocampus", "Humans", "Male", "Mice", "Middle Aged", "Protein-Serine-Threonine Kinases", "Protein-Tyrosine Kinases", "RNA-Seq", "Wnt Signaling Pathway"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85065697947", "SubjectAreas": [["Multidisciplinary", "MULT", "1000"]], "AuthorData": {"57112549000": {"Name": "Granno S.", "AuthorID": "57112549000", "AffiliationID": "60019953", "AffiliationName": "Department of Neuromuscular Diseases, UCL Institute of Neurology"}, "57188567996": {"Name": "Nixon-Abell J.", "AuthorID": "57188567996", "AffiliationID": "60013780", "AffiliationName": "Cell Biology Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke (NINDS)"}, "7102127302": {"Name": "Berwick D.C.", "AuthorID": "7102127302", "AffiliationID": "60012113", "AffiliationName": "School of Health, Life and Chemical Sciences, The Open University"}, "57189748019": {"Name": "Heaton G.", "AuthorID": "57189748019", "AffiliationID": "60016379, 60022148", "AffiliationName": "Department of Pharmacology, UCL School of Pharmacy, University College London"}, "57208754292": {"Name": "Almudimeegh S.", "AuthorID": "57208754292", "AffiliationID": "60016379, 60022148", "AffiliationName": "Department of Pharmacology, UCL School of Pharmacy, University College London"}, "57208761137": {"Name": "Nagda Z.", "AuthorID": "57208761137", "AffiliationID": "60016379, 60022148", "AffiliationName": "Department of Pharmacology, UCL School of Pharmacy, University College London"}, "7102029918": {"Name": "Harvey K.", "AuthorID": "7102029918", "AffiliationID": "60016379, 60022148", "AffiliationName": "Department of Pharmacology, UCL School of Pharmacy, University College London"}, "56906809400": {"Name": "Tosh J.", "AuthorID": "56906809400", "AffiliationID": "60019953", "AffiliationName": "Department of Neuromuscular Diseases, UCL Institute of Neurology"}, "56860860200": {"Name": "Cleverley K.", "AuthorID": "56860860200", "AffiliationID": "60019953", "AffiliationName": "Department of Neuromuscular Diseases, UCL Institute of Neurology"}, "14520663000": {"Name": "Wiseman F.K.", "AuthorID": "14520663000", "AffiliationID": "115862034", "AffiliationName": "London Down Syndrome Consortium (LonDownS)"}, "57203069236": {"Name": "Fisher E.M.C.", "AuthorID": "57203069236", "AffiliationID": "115862034", "AffiliationName": "London Down Syndrome Consortium (LonDownS)"}, "7005821923": {"Name": "Rain J.C.", "AuthorID": "7005821923", "AffiliationID": "60021511", "AffiliationName": "Hybrigenics Services - Fondation J\u00e9r\u00f4me Lejeune"}, "55354591700": {"Name": "Zanda M.", "AuthorID": "55354591700", "AffiliationID": "60022148", "AffiliationName": "UCL Genetics Institute"}, "16402494600": {"Name": "Plagnol V.", "AuthorID": "16402494600", "AffiliationID": "60022148", "AffiliationName": "UCL Genetics Institute"}, "7003735726": {"Name": "Tybulewicz V.L.J.", "AuthorID": "7003735726", "AffiliationID": "115862034", "AffiliationName": "London Down Syndrome Consortium (LonDownS)"}}}